Teledyne and Varex Filed Premerger Notifications
The companies have entered a 30-day regulatory waiting period in the U.S. as they seek international merger clearance.
Updated on Sept. 21, 2026 in Healthcare
Live Poll
Do you believe major corporate mergers typically benefit the average consumer?
Teledyne Technologies and Varex Imaging have submitted Hart-Scott-Rodino premerger notifications to U.S. regulators. This filing triggers a 30-day waiting period essential for the proposed merger.
Why it matters
The submission marks a critical step in navigating multi-jurisdictional compliance requirements. Securing these approvals is necessary before the companies can finalize their transaction.
The companies initiated a 30-day waiting period under the Hart-Scott-Rodino Act to satisfy U.S. review requirements. The merger remains subject to scrutiny across eight distinct international jurisdictions.
The players
Teledyne Technologies
An industrial conglomerate specializing in instrumentation, digital imaging, and aerospace and defense electronics.
Varex Imaging
A manufacturer of medical X-ray imaging components such as tubes, digital detectors, and software solutions.
The details
Companies submit Hart-Scott-Rodino notifications to the Federal Trade Commission and Department of Justice to disclose details of an impending merger. This process allows regulators to assess potential antitrust implications before the deal proceeds. Beyond the U.S., the firms must also secure clearance in Austria, China, Germany, Japan, Saudi Arabia, and Ukraine, alongside compliance with the United Kingdom's National Security and Investment Act of 2021.
Timeline
September 16, 2026: Companies filed Hart-Scott-Rodino premerger notifications.
October 16, 2026: Regulatory waiting period is scheduled to expire.
Market Landscape
This filing follows the standard notification procedures established by the Hart-Scott-Rodino Antitrust Improvements Act of 1976. The deal must navigate a complex web of global regulatory oversight, mirroring the increasing scrutiny faced by mid-to-large cap cross-border mergers.
Operators should monitor the October 16, 2026, deadline for updates on potential antitrust hurdles or regulatory stipulations. Market participants in the medical imaging sector should prepare for possible integration shifts pending successful international clearance.
The takeaway
Large-scale mergers require rigorous adherence to international notification statutes to ensure compliance before deal completion. Monitor the October 16, 2026, date to see if regulators request additional information or impose conditions on the transaction.
What happens next
The mandatory regulatory waiting period is set to expire on October 16, 2026.
Further reading
For more on industry consolidation, visit Healthcare.
Source note: This article includes information reported by Mlex.
Live Poll
Do you believe major corporate mergers typically benefit the average consumer?
